Comparison of the Results of Glassbone and Tricalcium Phosphate Graft Used in Bone Tumors
PDF
Cite
Share
Request
Original Article
P: 332-336
2020

Comparison of the Results of Glassbone and Tricalcium Phosphate Graft Used in Bone Tumors

Acta Haematol Oncol Turc 2020;53(2):332-336
1. Ankara Yıldırım Beyazıt University, Deparment Of Orthopedics And Traumotology, Ankara
2. Gulhane Training And Research Hospital, Orthopedics And Traumotology, Ankara
3. Dr Abdurrahman Yurtaslan Ankara Oncology Training And Research Hospital, Orthopedics And Traumotology, Ankara
4.
No information available.
No information available
Received Date: 2020-03-21T23:41:22
Accepted Date: 2020-09-04T11:22:05
PDF
Cite
Share
Request

Abstract

INTRODUCTION

Bone defects caused tumors sometimes may not heal with bone tissue. In such cases, bone defects may need to be filled with bone graft materials to facilitate or start healing. The purpose of our study is to compare results of glass graft(GG) (GlassBone NORAKER) and tricalcium phosphate (TCP) grafts that we use in benign bone cysts clinically and radiologically.

METHODS

41 patients with benign bone tumors (mostly simple bone cysts (SBC) and aneurysmal bone cysts (ABC) ) had been treated between either glass graft or tricalcium phosphate graft between 2013-2015. Patients were divided into two groups as those treated with GG and TCP grafts. Graft consolidation evaluated radiologically with x-rays monthly.

RESULTS

There were 20 men and 21 women (51.2%) with a mean age of 22.0 years (range 14-32 years). In patients using GG, compared to patients using TCP, radiological consolidation was observed faster between 14.-16. months (p = 0.0001).

DISCUSSION AND CONCLUSION

We conclude that in the treatment of benign bone tumors glassbone can be used as an alternative to tricalcium phosphate grafts. We also noticed that patients treated with glassbone showed a faster rate of fusion radiologically.